Molecular characterization of diffuse malignant peritoneal mesothelioma
Open Access
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 33 (11) , 2269-2279
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesotheliomaNature Genetics, 2011
- CDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survivalLaboratory Investigation, 2010
- Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005Cancer Causes & Control, 2009
- Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomasLaboratory Investigation, 2008
- Primary peritoneal mesotheliomas in children: a clinicopathological and immunohistochemical study of eight casesHistopathology, 2008
- Epidemiology of peritoneal mesothelioma: a reviewAnnals of Oncology, 2006
- P16 Loss and Mitotic Activity Predict Poor Survival in Patients with Peritoneal Malignant MesotheliomaClinical Cancer Research, 2005
- Diffuse malignant epithelial mesotheliomas of the peritoneum in womenCancer, 2002
- Malignant mesotheliomaAmerican Journal of Surgical Pathology, 1982